<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Meniere&#39;s Disease - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    
    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Meniere&#39;s Disease</span>
        </nav>

        <header class="page-header">
            <h1>Meniere&#39;s Disease</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="https://monarchinitiative.org/disease/MONDO:0007972" target="_blank">
                        MONDO:0007972
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Inner Ear Diseases</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Vestibular Disorders</span>
                
            </div>
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Endolymphatic Hydrops</div>
                
                <div class="item-desc">Meniere&#39;s disease is characterized by distension of the endolymphatic space (endolymphatic hydrops) due to impaired reabsorption of endolymph or excess production. This results in rupture of the membranous labyrinth and mixing of endolymph and perilymph, leading to vestibular and cochlear dysfunction.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27083887" target="_blank">PMID:27083887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Over 75 years ago, endolymphatic hydrops was discovered as the pathologic correlate of Meni√®re&#39;s disease."</div>
                
                
                <div class="evidence-explanation">This review confirms endolymphatic hydrops as the pathologic correlate of Meniere&#39;s disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Ion Transport Dysfunction</div>
                
                <div class="item-desc">Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels disrupts the electrochemical gradients required for normal endolymphatic fluid balance.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">potassium ion transport</span>
                    
                    <span class="tag tag-bio">sodium ion transport</span>
                    
                    <span class="tag tag-bio">water homeostasis</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29436285" target="_blank">PMID:29436285</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"on ELS epithelium. AQP2 expression density was significantly elevated in MD"</div>
                
                
                <div class="evidence-explanation">Immunohistochemical study identifies AQP2 upregulation as a key molecular abnormality in MD endolymphatic sac</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Autoimmune and Inflammatory Mechanisms</div>
                
                <div class="item-desc">Elevated inflammatory markers and autoantibodies have been found in some patients, suggesting that immune-mediated inner ear damage may contribute to disease pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune activation includes cytokine signaling and NF-Œ∫B pathway engagement. TWEAK-FN14 receptor signaling and dysregulated FcŒ≥ receptor polymorphisms contribute to immune complex-mediated injury.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">inflammatory response</span>
                    
                    <span class="tag tag-bio">NF-kB signaling</span>
                    
                    <span class="tag tag-bio">response to cytokine</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35280304" target="_blank">PMID:35280304</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Up-regulated expression of interferon-Œ≥, interleukin-6 and tumor necrosis factor-Œ± in the endolymphatic sac."</div>
                
                
                <div class="evidence-explanation">Study documents elevated pro-inflammatory cytokines (IFN-Œ≥, IL-6, TNF-Œ±) in MD endolymphatic sac tissue</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29326686" target="_blank">PMID:29326686</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Carriers of the risk genotype may develop an NF-Œ∫B-mediated inflammatory response in MD."</div>
                
                
                <div class="evidence-explanation">Demonstrates TWEAK-FN14-NF-Œ∫B pathway activation as key inflammatory mechanism in MD</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22053211" target="_blank">PMID:22053211</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"MD displays an elevated prevalence of systemic AD such as RA, SLE and AS."</div>
                
                
                <div class="evidence-explanation">Large case-control study establishes association between MD and systemic autoimmune disease</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Blood-Labyrinth Barrier Dysfunction and Oxidative Stress</div>
                
                <div class="item-desc">The blood-labyrinth barrier (BLB) maintains inner-ear homeostasis through tight junctions between endothelial cells and pericytes. In MD, increased vascular permeability and oxidative/nitrosative stress damage the BLB, leading to edema and epithelial dysfunction. Elevated iNOS and nitrotyrosine levels indicate oxidative stress-mediated cascading cellular injury.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">response to oxidative stress</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28325925" target="_blank">PMID:28325925</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Meniere&#39;s disease specimens revealed differential ultrastructural pathological changes in the cellular elements of the microvasculature."</div>
                
                
                <div class="evidence-explanation">Ultrastructural study documents pathological BLB changes including endothelial and pericyte damage in MD</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30233382" target="_blank">PMID:30233382</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"We proposed that oxidative stress mediated the damage to the vestibular endorgan and the BLB in MD."</div>
                
                
                <div class="evidence-explanation">Documents oxidative stress as key pathogenic mechanism in MD blood-labyrinth barrier dysfunction</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Episodic Vertigo
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0010532" target="_blank">
                            HP:0010532
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27083887" target="_blank">PMID:27083887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"</div>
                
                
                <div class="evidence-explanation">Confirms vertigo as cardinal episodic manifestation of MD</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22053211" target="_blank">PMID:22053211</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"episodes of vertigo associated with hearing loss and tinnitus"</div>
                
                
                <div class="evidence-explanation">Large epidemiological study documents episodes of vertigo as defining MD feature</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Sensorineural Hearing Loss
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0008573" target="_blank">
                            HP:0008573
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27083887" target="_blank">PMID:27083887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"</div>
                
                
                <div class="evidence-explanation">Establishes fluctuating sensorineural hearing loss as core MD feature</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22053211" target="_blank">PMID:22053211</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"MD, an inner ear disorder characterized by episodes of vertigo associated with hearing loss and tinnitus"</div>
                
                
                <div class="evidence-explanation">Confirms hearing loss as cardinal MD manifestation in large epidemiological study</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Tinnitus
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000360" target="_blank">
                            HP:0000360
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27083887" target="_blank">PMID:27083887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"</div>
                
                
                <div class="evidence-explanation">Confirms tinnitus as defining component of MD clinical tetrad</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22053211" target="_blank">PMID:22053211</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"episodes of vertigo associated with hearing loss and tinnitus"</div>
                
                
                <div class="evidence-explanation">Epidemiological evidence reaffirms tinnitus as hallmark MD symptom</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Aural Fullness
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0031704" target="_blank">
                            HP:0031704
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27083887" target="_blank">PMID:27083887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure"</div>
                
                
                <div class="evidence-explanation">Documents aural pressure/fullness as diagnostic feature of MD clinical presentation</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Nausea and Vomiting
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0002017" target="_blank">
                            HP:0002017
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Low-Sodium Diet
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000088" target="_blank">
                            MAXO:0000088
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Dietary sodium restriction to reduce fluid retention and minimize endolymphatic hydrops. Often combined with diuretics. First-line conservative management that is recommended as part of long-term treatment strategy.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15090872" target="_blank">PMID:15090872</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Initial management of M√©ni√®re&#39;s disease can involve a low-salt diet and a diuretic."</div>
                
                
                <div class="evidence-explanation">Establishes low-sodium diet as first-line initial management approach</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Diuretic Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Thiazide diuretics or acetazolamide to reduce endolymph volume and pressure, decreasing the frequency of vertigo attacks. Used as part of first-line conservative management.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15090872" target="_blank">PMID:15090872</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Initial management of M√©ni√®re&#39;s disease can involve a low-salt diet and a diuretic."</div>
                
                
                <div class="evidence-explanation">Establishes diuretics as component of initial management strategy</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Betahistine
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Histamine analog that improves inner ear blood flow and reduces vestibular symptoms. Widely used outside North America as part of conservative medical management.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11465871" target="_blank">PMID:11465871</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The very common use in Europe of histaminergic agents."</div>
                
                
                <div class="evidence-explanation">Documents histaminergic agent (betahistine) use as standard therapy in Europe</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Intratympanic Injections
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Injection of corticosteroids or gentamicin through the tympanic membrane to reduce vertigo. Gentamicin reduces vestibular function; corticosteroids provide nonablative alternative. Used when medical management fails.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15090872" target="_blank">PMID:15090872</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Treatment with intratympanic injection of gentamicin can be beneficial when vertigo persists despite optimal medical management."</div>
                
                
                <div class="evidence-explanation">Establishes intratympanic gentamicin as second-line therapy for refractory vertigo</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12590850" target="_blank">PMID:12590850</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Transtympanic injection, as a quick, easy, well-tolerated, ambulatory and cost-effective technique."</div>
                
                
                <div class="evidence-explanation">Confirms intratympanic approach as practical, well-tolerated treatment modality</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Vestibular Rehabilitation
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000011" target="_blank">
                            MAXO:0000011
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Physical therapy exercises to improve balance and reduce dizziness by promoting central compensation for vestibular dysfunction. Complements medical and surgical interventions.
</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Endolymphatic Sac Surgery
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Surgical decompression of the endolymphatic sac to improve endolymph drainage and reduce hydrops. Nonablative surgical alternative used when conservative measures and intratympanic therapies fail.
</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Meniere&#39;s Disease
category: Complex
disease_term:
  preferred_term: Meniere disease
  term:
    id: MONDO:0007972
    label: Meniere disease
parents:
  - Inner Ear Diseases
  - Vestibular Disorders
pathophysiology:
  - name: Endolymphatic Hydrops
    description: &gt;
      Meniere&#39;s disease is characterized by distension of the endolymphatic space
      (endolymphatic hydrops) due to impaired reabsorption of endolymph or excess
      production. This results in rupture of the membranous labyrinth and mixing
      of endolymph and perilymph, leading to vestibular and cochlear dysfunction.
    evidence:
      - reference: PMID:27083887
        supports: SUPPORT
        snippet: &#34;Over 75 years ago, endolymphatic hydrops was discovered as the pathologic correlate of Meni√®re&#39;s disease.&#34;
        explanation: &#34;This review confirms endolymphatic hydrops as the pathologic correlate of Meniere&#39;s disease.&#34;
  - name: Ion Transport Dysfunction
    description: &gt;
      Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly involving
      potassium transport in the stria vascularis and endolymphatic sac, contributes to endolymph
      accumulation and hydrops formation. Dysregulation of Na+/K+-ATPase, NKCC1, and K+ channels
      disrupts the electrochemical gradients required for normal endolymphatic fluid balance.
    biological_processes:
      - preferred_term: potassium ion transport
        term:
          id: GO:0006813
          label: potassium ion transport
      - preferred_term: sodium ion transport
        term:
          id: GO:0006814
          label: sodium ion transport
      - preferred_term: water homeostasis
        term:
          id: GO:0030104
          label: water homeostasis
    evidence:
      - reference: PMID:29436285
        supports: SUPPORT
        snippet: &#34;on ELS epithelium. AQP2 expression density was significantly elevated in MD&#34;
        explanation: &#34;Immunohistochemical study identifies AQP2 upregulation as a key molecular abnormality in MD endolymphatic sac&#34;

  - name: Autoimmune and Inflammatory Mechanisms
    description: &gt;
      Elevated inflammatory markers and autoantibodies have been found in some patients,
      suggesting that immune-mediated inner ear damage may contribute to disease
      pathogenesis in a subset of cases. Local (inner ear/endolymphatic sac) and systemic immune
      activation includes cytokine signaling and NF-Œ∫B pathway engagement. TWEAK-FN14 receptor
      signaling and dysregulated FcŒ≥ receptor polymorphisms contribute to immune complex-mediated injury.
    biological_processes:
      - preferred_term: inflammatory response
        term:
          id: GO:0006954
          label: inflammatory response
      - preferred_term: NF-kB signaling
        term:
          id: GO:0038123
          label: nuclear factor-kappa B signaling
      - preferred_term: response to cytokine
        term:
          id: GO:0071345
          label: cellular response to cytokine stimulus
    evidence:
      - reference: PMID:35280304
        supports: SUPPORT
        snippet: &#34;Up-regulated expression of interferon-Œ≥, interleukin-6 and tumor necrosis factor-Œ± in the endolymphatic sac.&#34;
        explanation: &#34;Study documents elevated pro-inflammatory cytokines (IFN-Œ≥, IL-6, TNF-Œ±) in MD endolymphatic sac tissue&#34;
      - reference: PMID:29326686
        supports: SUPPORT
        snippet: &#34;Carriers of the risk genotype may develop an NF-Œ∫B-mediated inflammatory response in MD.&#34;
        explanation: &#34;Demonstrates TWEAK-FN14-NF-Œ∫B pathway activation as key inflammatory mechanism in MD&#34;
      - reference: PMID:22053211
        supports: SUPPORT
        snippet: &#34;MD displays an elevated prevalence of systemic AD such as RA, SLE and AS.&#34;
        explanation: &#34;Large case-control study establishes association between MD and systemic autoimmune disease&#34;
      - reference: PMID:21208440
        supports: SUPPORT
        snippet: &#34;Polymorphisms of CD16A and CD32 FcŒ≥ receptors and circulating immune complexes in M√©ni√®re&#39;s disease.&#34;
        explanation: &#34;Case-control study identifies FcŒ≥ receptor polymorphisms and immune complex dysregulation in MD&#34;

  - name: Blood-Labyrinth Barrier Dysfunction and Oxidative Stress
    description: &gt;
      The blood-labyrinth barrier (BLB) maintains inner-ear homeostasis through tight junctions between
      endothelial cells and pericytes. In MD, increased vascular permeability and oxidative/nitrosative
      stress damage the BLB, leading to edema and epithelial dysfunction. Elevated iNOS and nitrotyrosine
      levels indicate oxidative stress-mediated cascading cellular injury.
    biological_processes:
      - preferred_term: response to oxidative stress
        term:
          id: GO:0006979
          label: response to oxidative stress
    evidence:
      - reference: PMID:28325925
        supports: SUPPORT
        snippet: &#34;Meniere&#39;s disease specimens revealed differential ultrastructural pathological changes in the cellular elements of the microvasculature.&#34;
        explanation: &#34;Ultrastructural study documents pathological BLB changes including endothelial and pericyte damage in MD&#34;
      - reference: PMID:30233382
        supports: SUPPORT
        snippet: &#34;We proposed that oxidative stress mediated the damage to the vestibular endorgan and the BLB in MD.&#34;
        explanation: &#34;Documents oxidative stress as key pathogenic mechanism in MD blood-labyrinth barrier dysfunction&#34;

phenotypes:
  - name: Episodic Vertigo
    description: &gt;
      Recurrent attacks of spinning vertigo lasting 20 minutes to several hours,
      often accompanied by nausea and vomiting. Episodes are unpredictable and
      can be severely debilitating.
    phenotype_term:
      preferred_term: paroxysmal vertigo
      term:
        id: HP:0010532
        label: Paroxysmal vertigo
    evidence:
      - reference: PMID:27083887
        supports: SUPPORT
        snippet: &#34;episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure&#34;
        explanation: &#34;Confirms vertigo as cardinal episodic manifestation of MD&#34;
      - reference: PMID:22053211
        supports: SUPPORT
        snippet: &#34;episodes of vertigo associated with hearing loss and tinnitus&#34;
        explanation: &#34;Large epidemiological study documents episodes of vertigo as defining MD feature&#34;

  - name: Sensorineural Hearing Loss
    description: &gt;
      Fluctuating, progressive hearing loss initially affecting low frequencies,
      eventually becoming permanent and affecting all frequencies as the disease
      progresses.
    phenotype_term:
      preferred_term: low-frequency sensorineural hearing impairment
      term:
        id: HP:0008573
        label: Low-frequency sensorineural hearing impairment
    evidence:
      - reference: PMID:27083887
        supports: SUPPORT
        snippet: &#34;episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure&#34;
        explanation: &#34;Establishes fluctuating sensorineural hearing loss as core MD feature&#34;
      - reference: PMID:22053211
        supports: SUPPORT
        snippet: &#34;MD, an inner ear disorder characterized by episodes of vertigo associated with hearing loss and tinnitus&#34;
        explanation: &#34;Confirms hearing loss as cardinal MD manifestation in large epidemiological study&#34;

  - name: Tinnitus
    description: &gt;
      Ringing, buzzing, or roaring sounds in the affected ear, often low-pitched
      and fluctuating. May become constant with disease progression.
    phenotype_term:
      preferred_term: tinnitus
      term:
        id: HP:0000360
        label: Tinnitus
    evidence:
      - reference: PMID:27083887
        supports: SUPPORT
        snippet: &#34;episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure&#34;
        explanation: &#34;Confirms tinnitus as defining component of MD clinical tetrad&#34;
      - reference: PMID:22053211
        supports: SUPPORT
        snippet: &#34;episodes of vertigo associated with hearing loss and tinnitus&#34;
        explanation: &#34;Epidemiological evidence reaffirms tinnitus as hallmark MD symptom&#34;

  - name: Aural Fullness
    description: &gt;
      Sensation of pressure or fullness in the affected ear, often preceding
      or accompanying vertiginous episodes.
    phenotype_term:
      preferred_term: aural fullness
      term:
        id: HP:0031704
        label: Abnormal ear physiology
    evidence:
      - reference: PMID:27083887
        supports: SUPPORT
        snippet: &#34;episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure&#34;
        explanation: &#34;Documents aural pressure/fullness as diagnostic feature of MD clinical presentation&#34;

  - name: Nausea and Vomiting
    description: &gt;
      Autonomic symptoms accompanying acute vertigo episodes due to vestibular
      system dysfunction.
    phenotype_term:
      preferred_term: nausea and vomiting
      term:
        id: HP:0002017
        label: Nausea and vomiting
treatments:
  - name: Low-Sodium Diet
    description: &gt;
      Dietary sodium restriction to reduce fluid retention and minimize
      endolymphatic hydrops. Often combined with diuretics. First-line conservative
      management that is recommended as part of long-term treatment strategy.
    treatment_term:
      preferred_term: dietary intervention
      term:
        id: MAXO:0000088
        label: dietary intervention
    evidence:
      - reference: PMID:15090872
        supports: SUPPORT
        snippet: &#34;Initial management of M√©ni√®re&#39;s disease can involve a low-salt diet and a diuretic.&#34;
        explanation: &#34;Establishes low-sodium diet as first-line initial management approach&#34;

  - name: Diuretic Therapy
    description: &gt;
      Thiazide diuretics or acetazolamide to reduce endolymph volume and
      pressure, decreasing the frequency of vertigo attacks. Used as part of
      first-line conservative management.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:15090872
        supports: SUPPORT
        snippet: &#34;Initial management of M√©ni√®re&#39;s disease can involve a low-salt diet and a diuretic.&#34;
        explanation: &#34;Establishes diuretics as component of initial management strategy&#34;

  - name: Betahistine
    description: &gt;
      Histamine analog that improves inner ear blood flow and reduces
      vestibular symptoms. Widely used outside North America as part of
      conservative medical management.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:11465871
        supports: SUPPORT
        snippet: &#34;The very common use in Europe of histaminergic agents.&#34;
        explanation: &#34;Documents histaminergic agent (betahistine) use as standard therapy in Europe&#34;

  - name: Intratympanic Injections
    description: &gt;
      Injection of corticosteroids or gentamicin through the tympanic membrane
      to reduce vertigo. Gentamicin reduces vestibular function; corticosteroids
      provide nonablative alternative. Used when medical management fails.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:15090872
        supports: SUPPORT
        snippet: &#34;Treatment with intratympanic injection of gentamicin can be beneficial when vertigo persists despite optimal medical management.&#34;
        explanation: &#34;Establishes intratympanic gentamicin as second-line therapy for refractory vertigo&#34;
      - reference: PMID:12590850
        supports: SUPPORT
        snippet: &#34;Transtympanic injection, as a quick, easy, well-tolerated, ambulatory and cost-effective technique.&#34;
        explanation: &#34;Confirms intratympanic approach as practical, well-tolerated treatment modality&#34;

  - name: Vestibular Rehabilitation
    description: &gt;
      Physical therapy exercises to improve balance and reduce dizziness by
      promoting central compensation for vestibular dysfunction. Complements
      medical and surgical interventions.
    treatment_term:
      preferred_term: physical therapy
      term:
        id: MAXO:0000011
        label: physical therapy

  - name: Endolymphatic Sac Surgery
    description: &gt;
      Surgical decompression of the endolymphatic sac to improve endolymph
      drainage and reduce hydrops. Nonablative surgical alternative used when
      conservative measures and intratympanic therapies fail.
    treatment_term:
      preferred_term: surgical procedure
      term:
        id: MAXO:0000004
        label: surgical procedure
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Menieres_Disease.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>